Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
1.32%1.86%17.16x1.15x2.07x8.57x11.41x 7.73B
0.5%0.53%18.14x2.39x4.9x12.92x14.83x 76.06B
2.53%2.75%23.31x2.82x4.23x12.3x14.2x 58.96B
0.6%0.62%39.69x4.11x6.14x19.91x27.51x 52.48B
-.--%-.--%50.21x6.77x13.28x28.8x36.1x 53.01B
-.--%-.--%16.18x1.38x2.8x8.54x9.75x 25.54B
-.--%-.--%15.46x3.25x2.96x9.4x9.02x 18.73B
-.--%0.02%78.56x7.71x9.37x84.18x96.59x 18.76B
-.--%-.--%-21.8x - 31.64x-32.06x-31.22x 14.48B
-.--%-.--%-593.65x2.76x4.32x11.23x24.28x 12.23B
-.--%-.--%-3.61x1.36x3.14x-1.85x-1.76x 11.51B
-.--%-.--%-16.04x - 521.12x-15.81x-15.97x 10.82B
-.--%-.--%18.95x1.66x2.82x13.06x13.78x 10.24B
2.82%1.83%6.42x2.69x3.03x4.52x4.57x 8.93B
-.--%-.--%-260.95x - - - - 8.46B
-.--%-.--%-39.08x164.46x11.7x-48.06x-42.48x 7.47B
-.--%-.--%38.76x - 16.95x39.83x40.49x 7.09B
Average 0.46% 0.45% -36.02x 15.58x 40.03x 9.72x 13.19x 23.68B
Weighted average by Cap. 0.63% 0.66% 0.11x 6.89x 21.36x 14.96x 18.89x
Biopharmaceuticals